Jm Favela-Hernández, I. Balderas-Rentería, G. Guerrero
{"title":"苏云金芽孢杆菌Cry1A-Cry2A毒素作为免疫原和佐剂的商业化产品的潜力","authors":"Jm Favela-Hernández, I. Balderas-Rentería, G. Guerrero","doi":"10.18689/mjim-1000114","DOIUrl":null,"url":null,"abstract":"1 Universidad Autónoma de Zacatecas, Unidad Académica de Ciencias Biológicas, Lab de Immunobiologia, Campus II-UAZ, Zacatecas, Zac, México 2Instituto Multidisciplinario de Ciencias (AVICENA), Campus Torreón, Coahuila, México 3 Universidad Autónoma de Nuevo León, Departamento de Investigación y Posgrado de la, Facultad de Ciencias Químicas, Lab de Ingeniería Genética y Genómica, Monterrey, Nvo León, México","PeriodicalId":304005,"journal":{"name":"Madridge Journal of Immunology","volume":"89 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"The Potential of a Commercial Product based on Bacillus thuringiensis Cry1A-Cry2A Toxins as an Immunogen and Adjuvant\",\"authors\":\"Jm Favela-Hernández, I. Balderas-Rentería, G. Guerrero\",\"doi\":\"10.18689/mjim-1000114\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"1 Universidad Autónoma de Zacatecas, Unidad Académica de Ciencias Biológicas, Lab de Immunobiologia, Campus II-UAZ, Zacatecas, Zac, México 2Instituto Multidisciplinario de Ciencias (AVICENA), Campus Torreón, Coahuila, México 3 Universidad Autónoma de Nuevo León, Departamento de Investigación y Posgrado de la, Facultad de Ciencias Químicas, Lab de Ingeniería Genética y Genómica, Monterrey, Nvo León, México\",\"PeriodicalId\":304005,\"journal\":{\"name\":\"Madridge Journal of Immunology\",\"volume\":\"89 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Madridge Journal of Immunology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18689/mjim-1000114\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Madridge Journal of Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18689/mjim-1000114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Potential of a Commercial Product based on Bacillus thuringiensis Cry1A-Cry2A Toxins as an Immunogen and Adjuvant
1 Universidad Autónoma de Zacatecas, Unidad Académica de Ciencias Biológicas, Lab de Immunobiologia, Campus II-UAZ, Zacatecas, Zac, México 2Instituto Multidisciplinario de Ciencias (AVICENA), Campus Torreón, Coahuila, México 3 Universidad Autónoma de Nuevo León, Departamento de Investigación y Posgrado de la, Facultad de Ciencias Químicas, Lab de Ingeniería Genética y Genómica, Monterrey, Nvo León, México